Details
Stereochemistry | ACHIRAL |
Molecular Formula | C12H9ClFN5 |
Molecular Weight | 277.685 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC=NC2=C1N=CN2CC3=C(F)C=CC=C3Cl
InChI
InChIKey=NAPNOSFRRMHNBJ-UHFFFAOYSA-N
InChI=1S/C12H9ClFN5/c13-8-2-1-3-9(14)7(8)4-19-6-18-10-11(15)16-5-17-12(10)19/h1-3,5-6H,4H2,(H2,15,16,17)
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL612888 Sources: https://www.ncbi.nlm.nih.gov/pubmed/3350108 |
7.0 µM [IC50] | ||
Target ID: CHEMBL612854 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | Unknown Approved UseUnknown |
|||
Curative | ARPOCOX Approved UseTreatment of Coccidiosis Launch Date1977 |
PubMed
Title | Date | PubMed |
---|---|---|
The therapeutic effect of 16 antimicrobial agents on Cryptosporidium infection in mice. | 1982 Apr |
|
Potent in vivo activity of arprinocid, a purine analogue, against murine toxoplasmosis. | 1986 Oct |
|
Toxoplasma gondii: in vivo and in vitro studies of a mutant resistant to arprinocid-N-oxide. | 1988 Apr |
|
In vitro cultivation of Cryptosporidium parvum and screening for anticryptosporidial drugs. | 1990 Aug |
|
Effectiveness of arprinocid in the reduction of cryptosporidial activity in immunosuppressed rats. | 1990 Oct |
|
In vitro model to assess effect of antimicrobial agents on Encephalitozoon cuniculi. | 1994 Oct |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4034245
Chicks: Medication of chicks with 70 p.p.m. arprinocid in the food, starting 2 days prior to inoculation with Eimeria tenella, resulted in decreased oocyst production and oocyst sporulation.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3350108
Arprinocid inhibited growth of Toxoplasma gondii in human fibroblasts at 2 ug/ml.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QP51AX11
Created by
admin on Sat Dec 16 17:31:22 GMT 2023 , Edited by admin on Sat Dec 16 17:31:22 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID3057773
Created by
admin on Sat Dec 16 17:31:22 GMT 2023 , Edited by admin on Sat Dec 16 17:31:22 GMT 2023
|
PRIMARY | |||
|
41574
Created by
admin on Sat Dec 16 17:31:22 GMT 2023 , Edited by admin on Sat Dec 16 17:31:22 GMT 2023
|
PRIMARY | |||
|
259-817-8
Created by
admin on Sat Dec 16 17:31:22 GMT 2023 , Edited by admin on Sat Dec 16 17:31:22 GMT 2023
|
PRIMARY | |||
|
6A0XTA8ZUH
Created by
admin on Sat Dec 16 17:31:22 GMT 2023 , Edited by admin on Sat Dec 16 17:31:22 GMT 2023
|
PRIMARY | |||
|
4341
Created by
admin on Sat Dec 16 17:31:22 GMT 2023 , Edited by admin on Sat Dec 16 17:31:22 GMT 2023
|
PRIMARY | |||
|
m570
Created by
admin on Sat Dec 16 17:31:22 GMT 2023 , Edited by admin on Sat Dec 16 17:31:22 GMT 2023
|
PRIMARY | Merck Index | ||
|
C166922
Created by
admin on Sat Dec 16 17:31:22 GMT 2023 , Edited by admin on Sat Dec 16 17:31:22 GMT 2023
|
PRIMARY | |||
|
100000086602
Created by
admin on Sat Dec 16 17:31:22 GMT 2023 , Edited by admin on Sat Dec 16 17:31:22 GMT 2023
|
PRIMARY | |||
|
SUB05569MIG
Created by
admin on Sat Dec 16 17:31:22 GMT 2023 , Edited by admin on Sat Dec 16 17:31:22 GMT 2023
|
PRIMARY | |||
|
ARPRINOCID
Created by
admin on Sat Dec 16 17:31:22 GMT 2023 , Edited by admin on Sat Dec 16 17:31:22 GMT 2023
|
PRIMARY | |||
|
CHEMBL321993
Created by
admin on Sat Dec 16 17:31:22 GMT 2023 , Edited by admin on Sat Dec 16 17:31:22 GMT 2023
|
PRIMARY | |||
|
55779-18-5
Created by
admin on Sat Dec 16 17:31:22 GMT 2023 , Edited by admin on Sat Dec 16 17:31:22 GMT 2023
|
PRIMARY |
ACTIVE MOIETY